More than half (183/348—53%) of tumor samples presented FGFR2-IIIb and ESRP1 overexpression and FGFR2-IIIc under-expression in comparison to the median expression of normal stomach samples (Figure 2c). The gene discussed is FGFR2; the disease is neoplasm.